Analytical Procedure Validation and the Quality by Design Paradigm

Since the adoption of the ICH Q8 document concerning the development of pharmaceutical processes following a quality by design (QbD) approach, there have been many discussions on the opportunity for analytical procedure developments to follow a similar approach. While development and optimization of analytical procedure following QbD principles have been largely discussed and described, the place of analytical procedure validation in this framework has not been clarified. This article aims at showing that analytical procedure validation is fully integrated into the QbD paradigm and is an essential step in developing analytical procedures that are effectively fit for purpose. Adequate statistical methodologies have also their role to play: such as design of experiments, statistical modeling, and probabilistic statements. The outcome of analytical procedure validation is also an analytical procedure design space, and from it, control strategy can be set.

[1]  M Haase,et al.  Stability testing on vaccines--results of activities of the International Conference on Harmonization (ICH) of technical requirements for registration of pharmaceuticals for human use. , 1994, Biologicals : journal of the International Association of Biological Standardization.

[2]  M Laurentie,et al.  Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part II. , 2004, Journal of pharmaceutical and biomedical analysis.

[3]  Philippe Hubert,et al.  Using total error as decision criterion in analytical method transfer , 2007 .

[4]  Benjamin Debrus,et al.  Design Spaces for analytical methods , 2013 .

[6]  F. E. Satterthwaite Synthesis of variance , 1941 .

[7]  Andre Raw,et al.  Quality by Design: Concepts for ANDAs , 2008, The AAPS Journal.

[8]  M Laurentie,et al.  Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part III. , 2007, Journal of pharmaceutical and biomedical analysis.

[9]  Benjamin Debrus,et al.  A Bayesian Design Space for Analytical Methods Based on Multivariate Models and Predictions , 2013, Journal of biopharmaceutical statistics.

[10]  P. Hubert,et al.  Using tolerance intervals in pre-study validation of analytical methods to predict in-study results. The fit-for-future-purpose concept. , 2007, Journal of chromatography. A.

[11]  李幼升,et al.  Ph , 1989 .

[12]  Pierre Lebrun,et al.  Evaluating the reliability of analytical results using a probability criterion: a Bayesian perspective. , 2011, Analytica chimica acta.

[13]  John J. Peterson,et al.  The ICH Q8 Definition of Design Space: A Comparison of the Overlapping Means and the Bayesian Predictive Approaches , 2010 .

[14]  M Laurentie,et al.  Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--Part I. , 2004, Journal of pharmaceutical and biomedical analysis.

[15]  Karl J. Friston,et al.  Variance Components , 2003 .

[16]  R. Marini,et al.  Quality by design compliant analytical method validation. , 2012, Analytical chemistry.